Tandem Diabetes Care Inc (TNDM)

NASD · Healthcare · Medical Devices · USA

Tandem Diabetes Care Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.

Tandem Diabetes Care develops and commercializes insulin delivery systems and related technology solutions for people living with insulin-dependent diabetes. The company offers durable insulin pumps, including t:slim X2 and Tandem Mobi, which integrate with continuous glucose monitoring sensors and feature automated insulin delivery algorithms. Its products serve customers worldwide through direct sales in North America and distributors internationally.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Tandem Diabetes Care Inc stock.

Our verdict on TNDM

Slightly undervalued: intrinsic value $18.20 per share, market price $17.06, margin of safety 6.3% (as of 2026-11-17).

A 1.4x revenue multiple, discounted for its losses, values the shares at $18.20; the price of $17.06 is 6% below that value.

ETFs with the most weight in TNDM

17 more funds hold it; the full list is part of the paid plan.

More on TNDM

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than TNDM in Medical Devices

10 more in this industry show a wider margin of safety.

Is TNDM undervalued or overvalued?

TNDM is slightly undervalued (as of the 2026-11-17 close). A 1.4x revenue multiple, discounted for its losses, values the shares at $18.20; the price of $17.06 is 6% below that value.

What is the intrinsic value of TNDM?

$18.20 per share (as of the 2026-11-17 close), against a market price of $17.06. That is a margin of safety of 6.3%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.